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Abstract
Background: Essential tremor (ET) is characterised by postural and action tremors with a frequency of 4–12 Hz. Previous
studies suggest that the tremor activity originates in the cerebello-thalamocortical pathways. Alprazolam is a short-acting
benzodiazepine that attenuates tremors in ET. The mechanisms that mediate the therapeutic action of alprazolam are
unknown; however, in healthy subjects, benzodiazepines increase cortical beta activity. In this study, we investigated the
effect of alprazolam both on beta and tremor-related cortical activity and on alterations in tremor presentation in ET
patients. Therefore, we characterised the dynamics of tremor and cortical activity in ET patients after alprazolam intake.
Methods: We recorded hand tremors and contralateral cortical activity in four recordings before and after a single dose of
alprazolam. We then computed the changes in tremors, cortico-muscular coherence, and cortical activity at the tremor
frequency and in the beta band.
Results: Alprazolam significantly attenuated tremors (EMG: 76.2622.68%), decreased cortical activity in the tremor
frequency range and increased cortical beta activity in all patients (P,0.05). At the same time, the cortico-muscular
coherence at the tremor frequency became non-significant (P,0.05). We also found a significant correlation (r= 0.757, P,
0.001) between the reduction in tremor severity and the increased ratio of cortical activity in the beta band to the activity
observed in the tremor frequency range.
Conclusions: This study provides the first quantitative analysis of tremor reduction following alprazolam intake. We
observed that the tremor severity decreased in association with an increased ratio of beta to tremor-related cortical activity.
We hypothesise that the increase in cortical beta activity may act as a blocking mechanism and may dampen the
pathological oscillatory activity, which in turn attenuates the observed tremor.
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Introduction
Essential tremor (ET) is a movement disorder caused by a
central oscillatory network and is characterised by postural and
action tremors ranging in frequency from 4–12 Hz [1]. The exact
mechanisms of tremor generation in essential tremor (ET) are still
unknown [2,3]. However, a number of studies implicate a
neuronal loop involving cerebello-thalamocortical pathways as
the locus of tremorogenesis [4–9]. In particular, the analysis of
coherence between cortical and muscle activity has demonstrated
the presence of tremor-related activity in cortical structures [6]
and has provided a method for studying the change in cortico-
muscular interaction over time [7].
Pharmacological treatments for ET remain limited and are only
partly effective [1,10]. The action mechanisms of these drugs are
unspecified, although it is assumed that they attenuate tremors by
interfering with the widespread pathological oscillations that occur
throughout the motor system [11]. Alprazolam, which is one of
several pharmacological alternatives for the treatment of ET, is a
short-acting benzodiazepine with an accepted classification of
probably efficacious (level B) agent [12–14].
Previous studies with healthy subjects have reported increased
cortical beta rhythm activity after the intake of other benzodiaz-
epines [15–18]. It is known that benzodiazepines increase the
affinity of the c-aminobutyric acid (GABA)-A receptor for its
neurotransmitter, which increases the size of the inhibitory
postsynaptic potentials that are generated by GABA neurotrans-
mission [19]. However, it is unclear how enhancing inhibition may
increase the power of the beta and gamma rhythms [18,20].
Because voluntary motor commands are projected to the
targeted motor unit populations in the beta band [21–23], we
hypothesised that the increase in cortical beta activity due to
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benzodiazepines would alter the transmission of descending motor
commands. Furthermore, we expected that such an increase in
oscillatory beta activity would impede the appearance of
pathological tremor-related cortical activity. Therefore, we ana-
lysed the interplay between cortical activity in the beta band and
tremor frequency after alprazolam intake to discern how this
interaction was associated with the drug effects on tremor and
cortico-muscular coupling at the tremor frequency.
Methods
Patients
Eight patients (two females, age 64.1613.2 years; mean 6 SD)
were included from a general neurology outpatient clinic (the
details are provided in Table 1). All patients were diagnosed with
ET according to the Movement Disorders Society Diagnostic
Criteria [24]. We excluded patients with severe tremors of the
hands or the head to avoid interference with the recordings. None
of the patients had other neurological conditions apart from ET or
suffered from psychiatric disorders. Additionally, none of the
patients were taking medication to treat their tremors or any other
drugs that could alter their tremors. The experimental protocol
was approved by the Ethical Committee of the University Hospital
‘‘12 de Octubre’’ (Madrid) and was in accordance with the
Declaration of Helsinki. All participants provided written informed
consent.
Recordings
Wrist tremors on the most affected side were measured with
solid-state gyroscopes and surface EMG. Two gyroscopes
(Technaid S.L., Madrid, Spain), placed on the hand dorsum and
the distal third of the forearm, measured wrist tremors by
computing the difference between them [25,26]. The data were
sampled at 50 Hz.
Surface EMG was recorded using a grid of 1365 electrodes (1
missing electrode), with 8 mm inter-electrode distance (LISiN–OT
Bioelettronica, Torino, Italy). The electrode grid was placed on the
wrist extensors and centred on the muscle exhibiting the clearest
tremorogenic activity; the common reference was set to the wrist
using a humidified bracelet. The data were amplified (EMGUSB,
OT Bioelettronica, Torino, Italy), band-pass filtered (10–750 Hz),
and sampled at 2,048 Hz.
EEG signals were recorded from 16 positions (F2, F4, FCz,
FC2, FC4, FC6, Cz, C2, C4, C6, T8, CP2, CP4, CP6, Pz and P4,
according to the International 10–20 system, when the left arm
was recorded; the symmetric positions were employed when the
right arm was recorded) using passive Au electrodes. We recorded
the cortical activity from the contralateral hemisphere because the
cortico-muscular coherence at the tremor frequency [6,7,27,28]
and within the beta band [23,29] are best observed at this location.
The reference was set to the common voltage of the two earlobes.
AFz was used as ground. The signal was amplified (gUSBamp,
g.Tecgmbh, Graz, Austria), band-pass (0.5–60 Hz) and notch
filtered (50 Hz), and sampled at 256 Hz.
The recording systems were synchronised with a common
digital signal. The data were analysed offline using Matlab (The
Mathworks Inc., Natick MA, USA) and SPSS (IBM, Chicago,
Illinois).
Procedure
The study was performed in a sound and light-attenuated room.
Patients sat in a comfortable chair with their arms supported.
During the measurement phase, all patients were instructed to
remain relaxed with their eyes open and their gaze fixated on a
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point on the wall. Patients were instructed not to eat or drink
anything (water was allowed) for 2 h before the recordings. To
evaluate the effects of alprazolam, patients underwent four, 4–min
recording sessions at different time points relative to alprazolam
administration as follows: before the administration of alprazolam
(Run0), immediately after (Run1), 40 min after (Run2), and
80 min after (Run3). Postural tremors were elicited by asking
patients to hold the measured hand outstretched with the palm
down and parallel to the ground. In patients who exhibited a very
mild tremor before the experiment (patients 02 and 04), weight
loads of 0.5 Kg were attached to the hand to enhance the tremor
[6,7].
A single dose of 0.50 mg of alprazolam was administered to
patients who weighed less than 75 kg; the remaining five patients
received a single dose of 0.75 mg. No patient reported adverse
effects. Two patients were excluded due to technical problems with
EEG acquisition (patient 03) and to the absence of tremors during
the measurement session (patient 05).
Data Processing and Analysis
The EEG signals were spatially filtered using the Hjorth
transform [30]. The resultant channels (FC2, FC4, C2, C4, C6,
CP2 and CP4) were used in the subsequent analyses. Artefacts
were removed based on visual inspection.
After the examination of the amplitude spectra of the gyroscope
and EMG data, we defined the tremor frequency range for our
group of patients as 4–9 Hz (see Fig. 1). This range was used to
estimate both the tremor power (measured with gyroscopes and
EMG) and the power of the tremor-related cortical activity.
To select the surface EMG channel that best characterised the
tremor, we used the criterion of maximising the signal-to-noise
ratio (SNR) of the tremor component of the EMG signal. The
SNR was defined as the ratio of the integral of the power spectral
density (PSD) within the tremor frequency range to the integral of
the PSD of the rest of the signal, similar to [6]. This channel was
used throughout the whole analysis.
The percentage of tremor reduction between the first and last
runs (Run0 and Run3) was computed by analysing the gyroscope
data. Tremor severity was defined as the integral of the PSD of the
signal in the tremor frequency range. Before the data were band-
pass filtered (2–15 Hz) to extract the tremor [26]. We also
calculated how the neural drive to the muscles related to tremors
was reduced after alprazolam intake by computing the percentage
of the tremor power decrease in Run1, Run2 and Run3 with
respect to Run0 for the EMG data.
Cortico-muscular coherence was computed to assess how the
tremor-related cortical drive to the muscle varied due to the effect
of alprazolam. We calculated the coherence between all the
processed EEG channels and the rectified EMG at the electrode
previously selected [31], and we chose the EEG channel that
exhibited the largest peak at the tremor frequency for the
subsequent calculations. We used the method for coherence
estimation proposed in [32]: the signals were divided into epochs
of 1 s, and their individual spectra and cross-spectra were
computed. Coherence was estimated as the ratio between the
squared cross-spectrum and the product of the two individual
power spectra [6,32]. The confidence limit was obtained as in
[33].
To study how alprazolam affected the tremor-related cortical
activity and the cortical activity in the beta band, we assessed the
changes in the EEG spectra by calculating the integral of the PSD
at the selected channel in the tremor frequency range (4–9 Hz, see
above) and in the beta band (13–30 Hz).
Statistical Analysis
We used the Wilcoxon rank sum test to compare the tremor
severity measured by the gyroscopes before (Run0) and 80 min
after the administration of alprazolam (Run3).
The Kruskal–Wallis test was used to compare the tremor-
related neural drive to the muscle in Run3, Run2 and Run1 with
respect to Run0. Significant differences between pairs of data were
assessed with the Games-Howell test, assuming non-equal
variances. The same test was used to compare the changes in
the power of cortical activity in the beta band and in the tremor-
frequency range and to compare the change in the ratio between
the activities in these two bands. In all cases, changes in Run3,
Run2 and Run1 were obtained with respect to Run0.
Finally, we calculated the Spearman’s rank correlation to
investigate the relationship between the decrease in tremor severity
(in terms of neural drive to the muscle, i.e., EMG) and the change
in the ratio between the EEG activity in the beta band and in the
tremor frequency range, using the data from Run3, Run2 and
Run1 with respect to Run0.
Results are reported as the mean 6 SD, and considered
significant if P,0.05.
Results
The tremor amplitude as measured with gyroscopes showed a
significant (P=0.029) reduction 80 min after the administration of
alprazolam (mean: 74.3630.2%). The mean tremor amplitudes
during Run0 and Run3 were 0.3160.34 rad2s22 and
0.04360.049 rad2s22, respectively.
Fig. 1 illustrates the change in tremorogenic muscle activity
across the different runs. There was a significant difference in the
tremor power reductions observed in Run3, Run2 and Run1
compared to Run0 (P=0.002). Post hoc analysis showed that the
decreases in tremor power observed in Run3 (mean: 75.0617.6%)
and in Run2 (mean: 69.3617.9%) were not significantly different
from each other (P=0.82); however, both were significantly larger
than that observed in Run1 (mean: 4.6623.6%) with respect to
Run0 (P,0.001 and P,0.001, respectively).
There were no significant differences (P=0.917, Wilcoxon rank
sum test) between the tremor frequency measured with the
gyroscopes (6.2260.53 Hz) and EMG (6.2060.56 Hz). The
tremor frequency did not change during the recordings, although
no statistics were obtained because the tremor was not clearly
identifiable in some patients after alprazolam intake (see Fig. 1C).
Fig. 2 depicts the coherence between the EEG channel with the
largest coherence at the tremor frequency and the selected EMG
channel. The coherence at the tremor frequency in Run0 was
significant (P,0.05) for all patients. In Run3, the coherence at the
tremor frequency decreased in all cases and fell below the
significance threshold in five out of seven patients. In the case of
patient 07, the significant coherence in Run3 was accompanied by
the observed rebound of EMG tremor power in Run3 with respect
to Run2 (Fig. 1).
Fig. 3 shows the time course of the EEG power spectrum along
the runs. Relative to Run0, there was a significant increase in the
ratio between the beta and tremor-related cortical activities for
Run3, Run2 and Run1 (P=0.003). Post hoc analysis showed no
significant difference between Run3 (mean 129.2696.7%) and
Run2 (mean 94.0648.5%) (P=0.68), but both were significantly
larger than Run1 (mean 9.81617.6%) (P=0.039 and P=0.007,
respectively).
When considered separately, the observed pattern of changes in
cortical beta activity and in cortical activity within the tremor
frequency range were similar. The increases in beta power in
Effects of Alprazolam on Essential Tremor
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Run1, Run2 and Run3 with respect to Run0 (5.763.6%,
54.4626.8% and 64.8629.2% respectively) were significantly
different (P = 0.002). Post hoc analyses showed that statistical
significance was achieved for the comparison between Run1 and
Run2 (P=0.007) and between Run1 and Run3 (P=0.004),
whereas the difference between Run2 and Run3 was not
statistically significant (P=0.77). The decrease of cortical activity
in the tremor frequency range was also significantly different in
Run1 (1.7615.4%), Run2 (18.1616.2%) and Run3 (23.1616.1%)
with respect to Run0 (P=0.035). However, post hoc analyses of
pairwise group comparisons did not achieve statistical significance.
A graph of these results is depicted in Fig. 4, where it is shown that,
after alprazolam intake, the cortical activity within the tremor
frequency range decreases and the cortical beta activity increases.
This effect can be observed for all patients 80 min after
alprazolam intake.
There was a significant correlation (r=0.757, P,0.001)
between the tremor power decrease (as measured with EMG)
and the increased ratio of beta to tremor-related activity in cortical
areas contralateral to the measured hand (in the EEG channel
where significant cortico-muscular coupling was best observed,
Fig. 4). This relation also held when analysing separately the
results of each patient, i.e., all of the patients presented a positive
relationship between both variables, as shown in Fig. 5.
Discussion
This study characterises the dynamics of tremor and cortical
activity in ET patients after alprazolam intake. We observed
significant changes in the measured tremor as well as in the
cortical activity both in the beta band and in the tremor frequency
range due to the effects of the drug. These changes revealed a
significant correlation between tremor reduction and the relative
change in cortical activity in the beta and tremor-related bands.
The study also provides the first quantitative evidence of tremor
changes after a single dose of alprazolam. Two previous studies
showed a significant improvement in tremor rating scales after
treating ET patients with alprazolam. Specifically, these studies
reported a 30% reduction in a double-blind placebo-controlled
trial [14], a 25% decrease in tremor intensity rated by functional
scores and a 46% increase in the global improvement scale by
patient self-evaluation [13]. Here, we confirm these results
quantitatively by showing a significant tremor reduction of
69.4% and 75.8% according to the EMG data (i.e., the neural
input to the muscle related to tremor) acquired 40 and 80 min
after a single dose of alprazolam. The timing of the observed
effects is also consistent with the time of peak concentration of
alprazolam reported for healthy elderly subjects (48618 min) [34].
The use of a low, single dose of alprazolam was aimed to avoid
drowsiness that induced EEG changes consistent with sedation
and were not related to the hypothesised anti-tremorogenic effect.
Figure 1. Time course of the tremor power measured with EMG. (A) Time course of the raw EMG (the amplitude scale is the same for all
subjects); (B) PSD of the EMG signals (one panel per patient).
doi:10.1371/journal.pone.0093159.g001
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In fact, the observed increase of EEG activity in the beta band
argues against a sedative effect of alprazolam because beta activity
is considered an index of cortical arousal [35].
We assessed the change in strength of cortico-muscular coupling
due to the effect of alprazolam. As expected [6,7,27,36], the
coherence values at the tremor frequency were significant in all
patients before drug intake. The coherence decreased 80 min after
alprazolam intake and was below the significance threshold in all
patients, except for patients 07 and 08. Interestingly, patient
07 also presented a rebound of tremor severity in Run3 compared
to Run2 (according to the EMG data) and demonstrated the
highest levels of the cortical beta activity 40 min after drug
administration. These data suggest an earlier onset and termina-
tion of the effects of alprazolam in this patient. Additionally, we
observed a decrease in the power of cortical activity in the tremor
frequency range in the EEG channel showing the largest
coherence at the tremor frequency. Taken together, these results
suggest that the pathological oscillatory activity in the cortex
decreased when the drug started to take effect. On the other hand,
coherent activity in the beta band was not evident in our results
either from the beginning of the session or during subsequent runs.
This finding is in contrast with the robust coherence at the beta
band observed in other studies; however, here, the patients
performed mild contractions to hold their hands extended, which
explains the lack of meaningful results in this regard [37,38].
We observed a significant increase in cortical beta activity in all
ET patients during a period after alprazolam intake, consistent
with previous research addressing the effects of other benzodiaz-
epines in healthy subjects [16,17]. Interestingly, the power of the
EEG activity at the beta band is also enhanced in alcoholics [39]
or after a small single dose of alcohol [40], and in 50–90% of ET
patients, alcohol acts to reduce the tremor amplitude [12,41].
While the precise mode of action of ethanol in ET has not been
established [42], its principal effect is likely mediated by the
potentiation of GABA-A receptors [43]. Although the effect of
these substances increasing the beta power measured with EEG
could not be related to its anti-tremorogenic effects, we observed a
significant relationship between an increase in the ratio of beta to
tremor-related cortical activity and a reduction in contralateral
postural tremor. Indeed, we observed this dependency for each
patient individually (Fig. 4). We acknowledge that this finding may
be an epiphenomenon or a consequence, albeit not necessarily
direct, of the biochemical effect of alprazolam on the brain.
Nevertheless, considering that during sustained motor contraction
the activity within cortical motor areas and their target muscles is
synchronised in the beta-range [22,23,44–46], we hypothesise that
the increased physiological beta activity in the primary motor
cortex may be interfering, at least in part, with the coupling of
pathological oscillatory networks involved in the generation of
tremor in ET.
Since EEG technology has limited spatial resolution, it cannot
be stated from our data that the cortical changes observed at the
tremor frequency after alprazolam intake are exclusively due to
changes in the tor cortex. Indeed, previous studies on cortico-
Figure 2. Cortico-muscular coherence. Obtained from Run0 and
Run3 (Run2 is included for patient 07 only). Each panel represents a
different patient. The significance level (P,0.05) is also displayed (solid
grey line).
doi:10.1371/journal.pone.0093159.g002
Figure 3. PSDs of the EEG data in the optimal channel for each
patient. The shaded areas represent the tremor frequency range
(yellow) and the beta band (green), as used to evaluate changes in the
cortical activity. Each panel represents a different patient.
doi:10.1371/journal.pone.0093159.g003
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muscular coherence in ET have pointed to a combined effect of
the afferent and efferent tracts [7]. It has also been shown that
existing techniques to detect the actual direction of information
flow are not always precise enough [47]. The main purpose of the
present study is to characterize the interaction between the central
(cortical) rhythms and the peripheral tremor. Indeed, we also
observed a significant correlation between the tremor reduction
and the increase in cortical beta activity by the effects of
alprazolam alone (results no included here). In that case, the
significance of the correlation was slightly smaller than the one
obtained using the ratio between the beta and the tremor-related
cortical activities but also suggested that there are changes in
cortical beta activity when tremor is reduced.
There is increasing evidence suggesting that Purkinje cells (PC)
and connected neuronal populations are centrally involved in the
generation of tremor in ET [42,48–51]. Regardless of whether ET
is a neurodegenerative disease affecting PC [51], or the result of
pacemaking neurons in the inferior olive [48–50], these structures
are controlled by GABAergic connections [52]. Recently, Paris-
Robidas et al. reported a post-mortem decrease in GABA
receptors in the dentate nucleus of the cerebellum from individuals
with ET (compared with controls or individuals with Parkinson’s
disease) that could result in disinhibition of cerebellar pacemaker
output activity [53]. Therefore, we are aware that the GABAergic
effect of alprazolam would not be restricted to the sensorimotor
cortex but could be spread through cerebello-thalamic pathways.
Indeed, localised microinjections of the GABA-A agonist musci-
mol into the ventral intermediate nucleus (in areas with
electrophysiologically identified tremor-synchronous cells) of ET
patients undergoing stereotaxy were effective at reducing tremor
[54].
Results presented here could be of pathophysiological interest,
providing biomarkers for alprazolam induced cortical activity
modulation in vivo. We also consider that the interplay between
cortical activity in the beta band and pathological tremor-related
cortical activity could be an easily measurable marker of efficiency,
providing new tools to assess the effect of novel therapeutic
strategies that enhance GABAergic inhibition with other mecha-
nisms instead of benzodiazepines.
Finally, the authors acknowledge several limitations of the
present study but consider that their impact on the conclusions is
minor. First, we recruited a small group of patients and thus our
results might not be generalisable to a broader population of ET
cases. However, the homogeneity of the results obtained from all
the patients separately (Fig. 5 shows that the identified positive
tendency is present in all cases) reinforces the hypothesis proposed
in this study. Second, we did not use a placebo group. However,
our data do not indicate that any of the patients experienced
placebo effects given that the observed reduction in tremor severity
4 min after alprazolam intake was negligible compared to
subsequent runs (Fig. 1). We consider that the results were not
influenced by expectancy bias because the patients had never
received alprazolam as treatment before and were unfamiliar with
the therapeutic effects of the drug to alleviate tremors.
In conclusion, we have shown that alprazolam attenuates
tremors in ET and increases the ratio between the beta and
tremor-related cortical activity as well as decreases the strength of
cortico-muscular coupling at the tremor frequency. We hypothe-
sise that the increase in cortical beta activity due to the effects of
alprazolam acts as a blocking mechanism of activity in patholog-
ical neural networks, which leads to a reduction of tremors in ET
patients. This is the first study to describe the neurophysiological
changes occurring in ET patients after benzodiazepine adminis-
tration, and it is expected that future experiments will identify
other drugs that reduce tremors in ET and that will enhance our
understanding of the pathophysiology of this disease and its
response to different treatments.
Figure 4. Changes (in %) of the cortical beta and tremor related
activities in Run1, Run2, and Run3 with respect to Run0. (A)
Decrease in the power of cortical activity within the tremor frequency
range. (B) Increase in the power of the beta band. (C) Increase in the
ratio between the power in the beta band and in the tremor frequency
range.
doi:10.1371/journal.pone.0093159.g004
Figure 5. Relationship between changes in tremor power and
the ratio between the beta and the tremor-related cortical
activities for all patients and runs. Run1, Run2 and Run3 (all with
respect to Run0) are represented with the symbols N, # and X,
respectively.
doi:10.1371/journal.pone.0093159.g005
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